Literature DB >> 24828098

Possible harms of theophylline in chronic obstructive pulmonary disease.

Claus F Vogelmeier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24828098      PMCID： PMC4098043          DOI： 10.3238/arztebl.2014.0291

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  9 in total

1.  Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Authors:  N Duffy; P Walker; F Diamantea; P M A Calverley; L Davies
Journal:  Thorax       Date:  2005-06-06       Impact factor: 9.139

2.  [Recommendations of the German Respiratory League for treatment of patients with chronic obstructive bronchitis and pulmonary emphysema].

Authors:  R Wettengel; W Böhning; U Cegla; C Criée; J Fichter; L Geisler; H Fabel; D Köhler; N Konietzko; H Lindemann
Journal:  Med Klin (Munich)       Date:  1995-01-15

3.  Salmeterol plus theophylline combination therapy in the treatment of COPD.

Authors:  R L ZuWallack; D A Mahler; D Reilly; N Church; A Emmett; K Rickard; K Knobil
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

Review 5.  Oral theophylline for chronic obstructive pulmonary disease.

Authors:  F S Ram; P W Jones; A A Castro; J A De Brito; A N Atallah; Y Lacasse; R Mazzini; R Goldstein; S Cendon
Journal:  Cochrane Database Syst Rev       Date:  2002

6.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Bartolome Celli; Stephen Senn; Deborah Burkhart; Steven Kesten; Shailendra Menjoge; Marc Decramer
Journal:  N Engl J Med       Date:  2008-10-05       Impact factor: 91.245

7.  The effects of theophylline on hospital admissions and exacerbations in COPD patients: audit data from the Bavarian disease management program.

Authors:  Johannes Fexer; Ewan Donnachie; Antonius Schneider; Stefan Wagenpfeil; Manfred Keller; Frank Hofmann; Michael Mehring
Journal:  Dtsch Arztebl Int       Date:  2014-04-25       Impact factor: 5.594

8.  Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD.

Authors:  B G Cosio; A Iglesias; A Rios; A Noguera; E Sala; K Ito; P J Barnes; A Agusti
Journal:  Thorax       Date:  2009-01-21       Impact factor: 9.139

Review 9.  Methylxanthines for exacerbations of chronic obstructive pulmonary disease.

Authors:  R G Barr; B H Rowe; C A Camargo
Journal:  Cochrane Database Syst Rev       Date:  2003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.